The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Open accessAbstract
Major histocompatibility complex (MHC)-restricted cytotoxic T lymphocytes (CTL) are part of the cellular immune response to human persistent virus infections. Measurements of the frequency and specificity of human immunodeficiency virus type 1 (HIV-1)-specific CTL and their variation with time may indicate their relative importance in modulating the progression of HIV-1 infection. We have used limiting dilution analysis (LDA) to derive quantitative estimates of the frequency of HIV-1-specific CTL precursors in a cross-sectional study of 23 patients at different clinical stages of HIV-1 infection and to compare these with the frequency of CTL precursors specific for another persistent virus (Epstein-Barr virus [EBV]) in the same patients. Peripheral blood mononuclear cells (PBMC) were stimulated in vitro with autologous HIV-1-infected lymphoblasts and assayed for cytotoxicity in 51Cr release assays against autologous and MHC-mismatched lymphoblastoid B cells infected with recombinant vaccinia viruses expressing the three HIV-1 structural gene products. The frequency of MHC-restricted precursors was high in asymptomatic HIV-1-infected patients (env-specific CTL precursors up to 73/10(6) PBMC; gag-specific CTL precursors up to 488/10(6) PBMC), although the relative frequency against the different structural gene products varied from patient to patient. The HIV-1-specific CTL precursor frequency was reduced in patients who had more severe (< 400/microliters) CD4+ lymphocyte depletion, while in the majority of such patients the frequency of CTL precursors against EBV was maintained at levels observed in healthy controls. Direct CTL activity in unstimulated PBMC was observed in three of nine patients but no correlation was found between the presence of an activated CTL response and the magnitude of the CTL response detected after stimulation in LDA. Thus, CTL precursors were detected against all three HIV-1 structural gene products in patients with CD4+ lymphocyte counts > 400/microliters, at frequencies that are high compared with those reported for other persistent viruses. A CTL response directed against multiple protein antigens of HIV-1 may protect the patient against epitope variation. The fact that the EBV-specific CTL precursor frequencies were maintained in advanced HIV-1 infection suggests that there may be selective impairment of the HIV-1-specific CTL response associated with disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G., Rothbard, J. A., Bangham, C. R. M., Rizza, C. R., et al. (1991) · Nature · doi:10.1038/354453a0 · Cited by 1,015
CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication
Walker, C. M., Moody, D. J., Stites, D. P., & Levy, J. A. (1986) · Science · doi:10.1126/science.2431484 · Cited by 990
Cytotoxic T-Cell Immunity to Influenza
McMichael, A. J., Gotch, F. M., Noble, G. R., & Beare, P. A. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198307073090103 · Cited by 927
Reusser, P., Riddell, Sr., Meyers, J., & Greenberg, P. (1991) · Blood · doi:10.1182/blood.v78.5.1373.1373 · Cited by 666
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations
Meyerhans, A., Cheynier, R., Albert, J., Seth, M., Kwok, S., Sninsky, J., Morfeldt-Månson, L., Asjö, B., & Wain-Hobson, S. (1989) · Cell · doi:10.1016/0092-8674(89)90942-2 · Cited by 651
Reddehase, M. J., Mutter, W., Münch, K., Bühring, H. J., & Koszinowski, U. H. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3102-3108.1987 · Cited by 423
Lindahl, K. F., & Wilson, D. B. (1977) · The Journal of experimental medicine · doi:10.1084/jem.145.3.508 · Cited by 358
Lin, Y. L., & Askonas, B. A. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.2.225 · Cited by 342
Limiting Dilution Analysis of Cells in the Immune System
Thompson, R. (1980) · Journal of Clinical Pathology · doi:10.1136/jcp.33.6.607-a · Cited by 324
Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.
Hoffenbach, A., Langlade-Demoyen, P., Dadaglio, G., Vilmer, E., Michel, F., Mayaud, C., Autran, B., & Plata, F. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.452 · Cited by 304
Cited by
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531
Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495
Mathematical Analysis of HIV-1 Dynamics in Vivo
Perelson, A. S., & Nelson, P. W. (1999) · SIAM Review · doi:10.1137/s0036144598335107 · Cited by 1,552
Jin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.991 · Cited by 1,407
Self-citationBorrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183
Goulder, P. J. R., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P., Luzzi, G., Morgana, B., Edwards, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-212 · Cited by 1,116
Brenchley, J. M., Karandikar, N. J., Betts, M. R., Ambrozak, D. R., Hill, B. J., Crotty, L. E., Casazza, J. P., Kuruppu, J., Migueles, S. A., Connors, M., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2103 · Cited by 1,073
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function
Appay, V., Nixon, D. F., Donahoe, S. M., Gillespie, G. M. A., Dong, T., King, A., Ogg, G. S., Spiegel, H. M. L., Conlon, C., Spina, C. A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.63 · Cited by 871
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
Rowland-Jones, S., Sutton, J., Ariyoshi, K., Dong, T., Gotch, F., McAdam, S., Whitby, D., Sabally, S., Gallimore, A., Corrah, T., et al. (1995) · Nature Medicine · doi:10.1038/nm0195-59 · Cited by 740
Wills, M. R., Carmichael, A. J., Mynard, K., Jin, X., Weekes, M. P., Plachter, B., & Sissons, J. G. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7569-7579.1996 · Cited by 688
Self-citationThe Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses
Kalams, S. A., & Walker, B. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2199 · Cited by 660
Rapid Effector Function in CD8+ Memory T Cells
Lalvani, A., Brookes, R., Hambleton, S., Britton, W. J., Hill, A. V. S., & McMichael, A. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.6.859 · Cited by 644
Klein, M. R., van Baalen, C. A., Holwerda, A. M., Kerkhof Garde, S. R., Bende, R. J., Keet, I. P., Eeftinck-Schattenkerk, J. K., Osterhaus, A. D., Schuitemaker, H., & Miedema, F. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1365 · Cited by 638
Cellular immune responses to HIV
McMichael, A. J., & Rowland-Jones, S. L. (2001) · Nature · doi:10.1038/35073658 · Cited by 616
Riddell, S. R., Elliott, M., Lewinsohn, D. A., Gilbert, M. J., Wilson, L., Manley, S. A., Lupton, S. D., Overell, R. W., Reynolds, T. C., Corey, L., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-216 · Cited by 565
Musey, L., Hughes, J., Schacker, T., Shea, T., Corey, L., & McElrath, M. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710303371803 · Cited by 518
Matano, T., Shibata, R., Siemon, C., Connors, M., Lane, H. C., & Martin, M. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.164-169.1998 · Cited by 487
Large clonal expansions of CD8+ T cells in acute infectious mononucleosis
Callan, M. F. C., Steven, N., Krausa, P., Wilson, J. D. K., Moss, P. A. H., Gillespie, G. M., Bell, J. I., Rickinson, A. B., & McMichael, A. J. (1996) · Nature Medicine · doi:10.1038/nm0896-906 · Cited by 473
Tumor-specific killer cells in paraneoplastic cerebellar degeneration
Albert, M. L., Darnell, J. C., Bender, A., Francisco, L. M., Bhardwaj, N., & Darnell, R. B. (1998) · Nature Medicine · doi:10.1038/3315 · Cited by 449
Gorochov, G., Neumann, A. U., Kereveur, A., Parizot, C., Li, T., Katlama, C., Karmochkine, M., Raguin, G., Autran, B., & Debré, P. (1998) · Nature Medicine · doi:10.1038/nm0298-215 · Cited by 427
Mitsuyasu, R. T., Anton, P. A., Deeks, S. G., Scadden, D. T., Connick, E., Downs, M. T., Bakker, A., Roberts, M. R., June, C. H., Jalali, S., et al. (2000) · Blood · doi:10.1182/blood.v96.3.785 · Cited by 425
Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells
Levy, J. A., Mackewicz, C. E., & Barker, E. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10011-6 · Cited by 420
Richman, D. D. (2001) · Nature · doi:10.1038/35073673 · Cited by 419
Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
Calarota, S., Bratt, G., Nordlund, S., Hinkula, J., Leandersson, A.-C., Sandström, E., & Wahren, B. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09440-3 · Cited by 400
Altfeld, M., Rosenberg, E. S., Shankarappa, R., Mukherjee, J. S., Hecht, F. M., Eldridge, R. L., Addo, M. M., Poon, S. H., Phillips, M. N., Robbins, G. K., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.169 · Cited by 385
Koenig, S., Conley, A. J., Brewah, Y. A., Jones, G. M., Leath, S., Boots, L. J., Davey, V., Pantaleo, G., Demarest, J. F., Carter, C., et al. (1995) · Nature Medicine · doi:10.1038/nm0495-330 · Cited by 377
Kalams, S. A., Buchbinder, S. P., Rosenberg, E. S., Billingsley, J. M., Colbert, D. S., Jones, N. G., Shea, A. K., Trocha, A. K., & Walker, B. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6715-6720.1999 · Cited by 369
Haque, T., Wilkie, G. M., Taylor, C., Amlot, P. L., Murad, P., Iley, A., Dombagoda, D., Britton, K. M., Swerdlow, A. J., & Crawford, D. H. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09672-1 · Cited by 363
Yang, O. O., Kalams, S. A., Trocha, A., Cao, H., Luster, A., Johnson, R. P., & Walker, B. D. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3120-3128.1997 · Cited by 340
Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion?
Effros, R. B., & Pawelec, G. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01079-7 · Cited by 336
In vivo migration and function of transferred HIV-1-specific cytotoxic T cells
Brodie, S. J., Lewinsohn, D. A., Patterson, B. K., Jiyamapa, D., Krieger, J., Corey, L., Greenberg, P. D., & Riddell, S. R. (1999) · Nature Medicine · doi:10.1038/4716 · Cited by 331
Deeks, S. G., Wagner, B., Anton, P. A., Mitsuyasu, R. T., Scadden, D. T., Huang, C., Macken, C., Richman, D. D., Christopherson, C., June, C. H., et al. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0611 · Cited by 324
ESCAPE OF HUMAN IMMUNODEFICIENCY VIRUS FROM IMMUNE CONTROL
McMichael, A. J., & Phillips, R. E. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.271 · Cited by 323
Kalams, S. A., Goulder, P. J., Shea, A. K., Jones, N. G., Trocha, A. K., Ogg, G. S., & Walker, B. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6721-6728.1999 · Cited by 308
Hanke, T., Samuel, R. V., Blanchard, T. J., Neumann, V. C., Allen, T. M., Boyson, J. E., Sharpe, S. A., Cook, N., Smith, G. L., Watkins, D. I., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7524-7532.1999 · Cited by 304
Donaghy, H., Gazzard, B., Gotch, F., & Patterson, S. (2003) · Blood · doi:10.1182/blood-2002-10-3189 · Cited by 274
Bhardwaj, N., Bender, A., Gonzalez, N., Bui, L. K., Garrett, M. C., & Steinman, R. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117399 · Cited by 269
McMichael, A. J., & O'Callaghan, C. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1367 · Cited by 263
Kuroda, M. J., Schmitz, J. E., Barouch, D. H., Craiu, A., Allen, T. M., Sette, A., Watkins, D. I., Forman, M. A., & Letvin, N. L. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1373 · Cited by 262
Rehermann, B., Chang, K. M., McHutchinson, J., Kokka, R., Houghton, M., Rice, C. M., & Chisari, F. V. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.7092-7102.1996 · Cited by 260
Lehner, P. J., Wang, E. C., Moss, P. A., Williams, S., Platt, K., Friedman, S. M., Bell, J. I., & Borysiewicz, L. K. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.79 · Cited by 258
Self-citation
Metadata
- Authors
- Carmichael, A., Jin, X., Sissons, P., & Borysiewicz, L.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-02-01
- Volume
- 177
- Issue
- 2
- Pages
- 249-256
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2071459721
- Cited by
- 418
- References
- 20
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.